Serbian tennis player Novak Djokovic owns 80% of the capital of a Danish biotechnology company that is looking for a cure against the coronavirus, among other objectives. The athlete made the investment in June 2020, as revealed by the CEO of the pharmaceutical company (QuantBioRes) and that the Reuters agency has advanced.
The most striking of this investment, whose economic amount has not been revealed, . Djokovic was held in Australia for not being vaccinated and, after a trial, was deported, prohibiting him from participating in the oceanic country’s tennis tournament. The athlete has not made any statements regarding this purchase made at the beginning of the pandemic.
QuantBioRes has about 11 researchers working in Denmark, Australia and Slovenia, according to its CEO, who stressed that they were working on a coronavirus treatment, according to Reuters. The news agency explains that the company is developing a peptide that prevents the coronavirus from infecting the human cell and hopes to launch clinical trials in Britain this summer.
Beyond this purchase, Djokovic continues to be a protagonist in Spain. After his controversy in Australia, now comes the possibility that the scene will be repeated for the tournament in Madrid. “We have known mobility restrictions (the digital vaccination certificate or a negative diagnostic test) so if the tennis player meets either of these two characteristics, he will be able to enter Spain,” explained this Wednesday the Minister of Industry at the Galician stand at Fitur.
Facebook Comments
Disqus